Skip to content
HowShorted

Gossamer Bio, Inc. short interest in 2020

In 2020, Gossamer Bio, Inc.'s disclosed short interest ran from 7.40% of shares outstanding on 15 Jan 2020 to 10.39% on 31 Dec 2020, a change of +2.99 percentage points. The year's high was 13.74% on 15 Oct 2020 and its low 6.81% on 15 May 2020, averaging 9.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.39 days on 31 Aug 2020. Full history: Gossamer Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Gossamer Bio, Inc. in 2020

2020 in figures

Start of year
7.40% (15 Jan 2020)
End of year
10.39% (31 Dec 2020)
Change
+2.99 pp
High
13.74% (15 Oct 2020)
Low
6.81% (15 May 2020)
Average
9.64%
Highest days to cover
31.39 (31 Aug 2020)
SEC filings marked
8

Every report in 2020

Gossamer Bio, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20207.40%11.48
31 Jan 20208.46%12.95
14 Feb 20208.06%17.35
28 Feb 20207.82%15.76
13 Mar 20207.64%11.64
31 Mar 20207.43%10.7610-K filed, results (8-K)
15 Apr 20207.57%14.60
30 Apr 20207.12%16.46
15 May 20206.81%11.0610-Q filed, results (8-K)
29 May 20208.82%3.68
15 Jun 20208.58%10.20
30 Jun 20208.75%8.59
15 Jul 202010.84%16.21
31 Jul 202011.86%12.95
14 Aug 202010.74%19.5710-Q filed, results (8-K)
31 Aug 202010.67%31.39
15 Sep 202010.74%29.91
30 Sep 202013.00%17.87
15 Oct 202013.74%6.61
30 Oct 202013.23%12.00
13 Nov 202010.59%16.5310-Q filed, results (8-K)
30 Nov 202011.03%21.90
15 Dec 202010.13%8.50
31 Dec 202010.39%9.67

See also: Gossamer Bio, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.